Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, October 22, 2026

Back to today

From X

@StableBread

Fajasy on X

Elmet $ELMT won a ~$36M U.S. defense stockpile contract for metal its plants already make, while deliveries under its $2B stockpile contract wait on new supply. On September 30, Elmet announced the award from the Defense Logistics Agency (DLA), which manages the U.S. National Defense Stockpile. It covers TZM (titanium-zirconium-molybdenum alloy) billets, bar stock, and ingots, plus molybdenum and tungsten wire, materials used to make jet engine components. Elmet's $2B stockpile contract, announced September 14, is separate and covers tungsten concentrate, the upgraded ore a mine ships. The $36M is 27.4% of Elmet's $131.5M total backlog at July 3 ($36M / $131.5M), and the release doesn't say when deliveries start or how long the contract runs. On the slide for the $2B contract, Elmet's October 1 deck says Elmet "does not intend to begin delivering material into the National Defense Stockpile until sufficient incremental new supply is available." Elmet's supply agreement with Tungsten West (AIM: TUN) puts concentrate from Hemerdon, its tungsten mine in Devon, England, first in line for Elmet's DLA deliveries until Elmet's Nevada refinery is commissioned (targeted for 1H 2029). Elmet expects >1,000 tonnes a year of Hemerdon concentrate, and the mine targets full production by the end of Q1 2027. In September I treated $1.85B of the $2B ceiling as an upper bound, not orders Elmet has in hand, and the $36M sits outside the $2B entirely. So the stockpile's newest award goes to metal from Elmet's existing U.S. plants, while the $2B contract still waits on a mine in England that isn't at full production yet.
@MaiusPartners 2 clicks

Maius on X

Some $PSIX thoughts off the recent 8-K: The banking syndicate lifted committed capacity from $135m to $220m (+$85m), cut the SOFR margin from +2.60% to +1.80%, and pushed maturity from July 2027 to September 2029 (~26 months). Credit committees are structurally risk-averse. More exposure, less spread, and longer tenor only clears if they like the repayment case. So what are they underwriting that most equity investors still won’t touch? Two things the disclosures imply: 1) Weichai’s North American strategy is locked in. Change-of-control remains tied to Weichai keeping board control and ≥40% ownership (same economic threshold as before). The extension removes left-tail risk that Weichai pursues a different go-to-market path. 2) The extra capacity isn’t for today’s balance sheet. Net debt was essentially zero at Q2’26 (cash ~$70m, debt ~$73m). The new investor materials flag Prime Power as a deliverable for the first time—ranges that overlap $INIO’s data-center gas engines, a segment where $INIO recently highlighted as an area "Chinese players have historically struggled to break in" and hence command "100% market share in several datacenter power ranges". As Bezos put it: your margin is my opportunity. Have a great weekend, everybody!

Investor Letters

All letters

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4B
Monte Independent Investment Research 5 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.5B
Latticework by MOI Global 26 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.5B
Latticework by MOI Global 4 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $108M
Triple S Special Situations Investing 4 clicks
UNCY · long

Unicycive Therapeutics INC

Unicycive Therapeutics fell nearly 50% after a second FDA Complete Response Letter tied to a third-party manufacturer for its primary…

UNCY $108M
Value Investors Club

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $291M
Guardian Research 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 56 of 248

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

90 accounts
Nominate an account

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.